Whitehawk Therapeutics (WHWK) Goodwill & Intangibles (2021 - 2022)

Whitehawk Therapeutics' (WHWK) quarterly Goodwill & Intangibles came in at $3.7 million in Q1 2022, down 1.78% on a QoQ basis from $3.8 million in Q4 2021.

Whitehawk Therapeutics (WHWK) Goodwill & Intangibles (2021 - 2022) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 2 years of Goodwill & Intangibles data on file, last reported at $3.7 million in Q1 2022.

  • On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $3.7 million in Q1 2022; TTM through Mar 2022 was $3.7 million, a N/A change from a year earlier, with the FY2021 full-year figure at $3.8 million, changed N/A from the prior year.
  • Goodwill & Intangibles for Q1 2022 stood at $3.7 million, down from $3.8 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for WHWK reached as high as $3.9 million in Q3 2021 and fell as low as $3.7 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Whitehawk Therapeutics 256.87 Mn 45.62 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 3.74 Mn
Dec 31, 2021 3.81 Mn
Sep 30, 2021 3.88 Mn